KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Return on Assets (2016 - 2025)

Historic Return on Assets for Neogenomics (NEO) over the last 17 years, with Q4 2025 value amounting to 0.08%.

  • Neogenomics' Return on Assets fell 300.0% to 0.08% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.08%, marking a year-over-year decrease of 300.0%. This contributed to the annual value of 0.07% for FY2025, which is 200.0% down from last year.
  • Per Neogenomics' latest filing, its Return on Assets stood at 0.08% for Q4 2025, which was down 300.0% from 0.08% recorded in Q3 2025.
  • In the past 5 years, Neogenomics' Return on Assets ranged from a high of 0.04% in Q2 2021 and a low of 0.09% during Q3 2022
  • Over the past 5 years, Neogenomics' median Return on Assets value was 0.05% (recorded in 2023), while the average stood at 0.05%.
  • In the last 5 years, Neogenomics' Return on Assets skyrocketed by 500bps in 2021 and then crashed by -1200bps in 2022.
  • Neogenomics' Return on Assets (Quarter) stood at 0.0% in 2021, then crashed by -1767bps to 0.08% in 2022, then skyrocketed by 37bps to 0.05% in 2023, then grew by 8bps to 0.05% in 2024, then tumbled by -65bps to 0.08% in 2025.
  • Its last three reported values are 0.08% in Q4 2025, 0.08% for Q3 2025, and 0.07% during Q2 2025.